These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34677571)

  • 21. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Giamouzis G; Karvounis H; Tzikas A; Giannakoulas G
    J Thromb Thrombolysis; 2019 Aug; 48(2):225-232. PubMed ID: 30830586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study.
    Grymonprez M; De Backer TL; Capiau A; Vauterin D; Mehuys E; Boussery K; Steurbaut S; Lahousse L
    Br J Clin Pharmacol; 2023 Apr; 89(4):1360-1373. PubMed ID: 36321924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
    Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
    J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Khurshid S; Weng LC; Hulme OL; Ellinor PT; Lubitz SA
    Am J Cardiol; 2017 Oct; 120(8):1316-1321. PubMed ID: 28823487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
    Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
    BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Masunaga N; Abe M; Ogawa H; Aono Y; Ikeda S; Doi K; An Y; Ishii M; Iguchi M; Esato M; Tsuji H; Wada H; Hasegawa K; Lip GYH; Akao M;
    Circ J; 2018 Nov; 82(12):2983-2991. PubMed ID: 30381701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study.
    Hohnloser SH; Basic E; Nabauer M
    Thromb Haemost; 2019 Jun; 119(6):882-893. PubMed ID: 30900220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
    Mazurek M; Halperin JL; Huisman MV; Diener HC; Dubner SJ; Ma CS; Rothman KJ; Healey JS; Teutsch C; Paquette M; França LR; Lu S; Bartels DB; Lip GYH
    Europace; 2020 Jan; 22(1):47-57. PubMed ID: 31651951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
    Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
    Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke.
    Lee M; Lee BC; Yu KH; Oh MS; Kim BJ; Kim JY; Kang J; Lee KJ; Kim DY; Park JM; Kang K; Park TH; Lee KB; Hong KS; Park HK; Cho YJ; Kim DE; Lee SJ; Kim JG; Lee J; Cha JK; Kim DH; Kim JT; Choi KH; Choi JC; Sohn SI; Hong JH; Lee SH; Kim C; Shin DI; Yum KS; Lee J; Lee JS; Gorelick PB; Bae HJ;
    Stroke; 2024 Mar; 55(3):625-633. PubMed ID: 38328909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
    Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
    Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis.
    Mendoza PA; McIntyre WF; Belley-Côté EP; Wang J; Parkash R; Atzema CL; Benz AP; Oldgren J; Whitlock RP; Healey JS;
    J Thromb Thrombolysis; 2022 Jan; 53(1):74-82. PubMed ID: 34338944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
    Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
    Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation/atrial flutter discharged from the emergency department: REMINDER study.
    Rezazadeh S; Chew DS; Miller RJH; Klassen S; Pournazari P; Bennett G; Lang E; Quinn FR
    CJEM; 2018 Nov; 20(6):841-849. PubMed ID: 30295590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.